Regulation of replicative and stress-induced senescence by RSK4, which is down-regulated in human tumors

Laura López-Vicente1, Gemma Armengol, Berta Pons

  • 1Department of Pathology, Vall d'Hebron University Hospital, and Department of Biochemistry and Molecular Biology, and Unit of Biological Anthropology, Universitat Autònoma de Barcelona, Barcelona 08035, Spain.

Abstract

Insights

The RSK4 gene, often downregulated in colon and renal carcinomas, acts as a tumor suppressor by inducing senescence and controlling cell proliferation. Its restoration may offer therapeutic potential in cancer treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Genetics

Background:

  • Cellular senescence is critical for understanding and controlling cell transformation.
  • RSK4 gene was identified in an RNA interference screen as being related to p53-dependent cell arrest.
  • Investigating RSK4's function is key to understanding its role in cancer development.

Purpose of the Study:

  • To investigate the potential role of RSK4 as a tumor suppressor gene.
  • To determine the impact of RSK4 on cell proliferation and senescence.
  • To explore RSK4's involvement in colon and renal carcinogenesis.

Main Methods:

  • Quantitative real-time PCR and immunoblotting were used to assess RSK4 expression in tumor samples and cell lines.
  • RSK4 cDNA and shRNA were used to manipulate RSK4 expression in colon carcinoma cell lines and human fibroblasts.
  • Senescence was induced via replicative stress and analyzed through molecular techniques.

Main Results:

  • RSK4 gene was significantly downregulated in colon carcinomas, renal cell carcinomas, and colon adenomas.
  • Overexpression of RSK4 induced cell cycle arrest and senescence features in normal and cancer cells.
  • RSK4 levels increased during both replicative and stress-induced senescence, and its suppression conferred resistance to cisplatin treatment.

Conclusions:

  • RSK4 functions as a tumor suppressor gene by modulating senescence induction.
  • RSK4 plays a role in controlling cell proliferation, particularly in colon and renal cancers.
  • These findings suggest RSK4 as a potential therapeutic target for cancer treatment.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...